The role of the funder is stated incorrectly in the Financial Disclosure (FD) statement of this article. Please refer to the correct FD statement below:
This study was sponsored by sanofi-aventis K.K. Dr. Tetsuya Ohtani is an employee of sanofi-aventis KK and received salary from sanofi-aventis KK. The funder had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.
Citation: The PLOS ONE Staff (2014) Correction: Potential Formula for the Calculation of Starting and Incremental Insulin Glargine Doses: ALOHA Subanalysis. PLoS ONE 9(7): e103390. https://doi.org/10.1371/journal.pone.0103390
Published: July 18, 2014
Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.